RISK OF INFECTIONS BETWEEN JAK INHIBITORS AND TNF INHIBITORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Choi, S. R. [1 ]
Shin, A. [1 ]
Ha, Y. J. [1 ]
Lee, Y. J. [1 ]
Lee, E. B. [2 ]
Kang, E. H. [1 ]
机构：
[1] Seoul Natl Univ, Div Rheumatol, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[2] Seoul Natl Univ Hosp, Div Rheumatol, Dept Internal Med, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Safety; Rheumatoid arthritis; Disease-modifying drugs (DMARDs);
D O I：
10.1136/annrheumdis-2023-eular.5291
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0836
引用
收藏
页码：716 / 716
页数：1
相关论文
共 50 条
  • [21] How Fast Do JAK-inhibitors, TNF- inhibitors, Abatacept and IL-6 Inhibitors Act in Rheumatoid Arthritis? An International Collaboration of Registers of Rheumatoid Arthritis Patients (the "JAK-pot" Study)
    Courvoisier, Delphine Sophie
    Mrad, Yacine
    Mongin, Denis
    Aymon, Romain
    Caporali, Roberto
    Choquette, Denis
    Codreanu, Catalin
    Coupal, Louis
    Huschek, Doreen
    Hyrich, Kimme
    Iannone, Florenzo
    Kvien, Tore K.
    Mustak, Monika
    Nordstrom, Dan
    Trokovic, Nina
    Otero-Varela, Lucia
    Pavelka, Karel
    Suarez, Manuel Enrique Pombo
    Provan, Sella A.
    Rodrigues, Ana Maria
    Rotar, Ziga
    Sidiropoulos, Prodromos
    Strangfeld, Anja
    Zavada, Jakub
    Zhao, Sizheng
    Finckh, Axel
    Lauper, Kim
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1014 - 1017
  • [22] Real Life Severe Infections in Patients with Rheumatoid Arthritis on Treatment with Biological Therapy and JAK Inhibitors
    Vega-Alvarez, Lucia
    Calvo-Zorrilla, Itziar
    Ibarguengoitia-Barrena, Oihane
    Blanco-Madrigal, Juan M.
    Montero-Seisdedos, David
    Garcia-Gomez, Carmen L.
    Esther Ruiz-Lucea, Maria
    Inchaurbe-Pellejero, Ana R.
    Torre-Salaberri, Ignacio
    Perez-Velasquez, Clara E.
    Fernandez-Berrizbeitia, Olaia
    Cuende-Quintana, Eduardo
    Gorostiza-Hormaetxe, Inigo R.
    Luz Garcia-Vivar, Maria
    Galindez-Agirregoikoa, Eva
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [23] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Kang, Eun Ha
    Liao, Katherine P.
    Kim, Seoyoung C.
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (07)
  • [24] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Eun Ha Kang
    Katherine P. Liao
    Seoyoung C. Kim
    Current Rheumatology Reports, 2018, 20
  • [25] Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
    Harigai, Masayoshi
    RHEUMATOLOGY, 2019, 58 : 34 - 42
  • [26] JAK INHIBITORS IN REFRACTORY AND AT-RISK COMORBID PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE
    Al Tabaa, O.
    Hecquet, S.
    Thomas, M.
    Carves, S.
    Combier, A.
    Richard, C. Miceli
    Fogel, O.
    Molto, A.
    Allanore, Y.
    Avouac, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1420 - 1420
  • [27] TNFα inhibitors for the treatment of rheumatoid arthritis
    Sany, J
    Kaiser, MJ
    ANNALES DE MEDECINE INTERNE, 2002, 153 (01): : 34 - 40
  • [28] TNF-α inhibitors and rheumatoid arthritis
    Shire, MG
    Muller, GW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (05) : 531 - 544
  • [29] RHEUMATOID ARTHRITIS TNF inhibitors and cardiovascular risk management in RA
    Pope, Janet E.
    NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (06) : 317 - U17
  • [30] The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis A Systematic Review and Network Meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E407 - E414
12345